Metabolic syndrome is a risk factor for cardiovascular disease. People with chronic schizophrenia are at risk for metabolic syndrome because of their diets, lifestyle, and (in some cases) their medication. The increased risk of metabolic syndrome has implications for the delivery of care to this population. This article provides an overview of metabolic syndrome in patients with schizophrenia and evidence-based criteria for monitoring this population. A recommendation is made to aggregate data collection in one place to facilitate follow-up. A sample form and letter are provided.